- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Increased HbA1c and HOMA-IR may predict risk of gestational diabetes early in pregnancy
China: According to a study published in Diabetes Research and Clinical Practice, researchers have concluded that there is an increased incidence of gestational diabetes mellitus (GDM) with increasing HbA1c and HOMA-IR.
They also mentioned that gestational diabetes risk is higher when both HbA1c and HOMA-IR are higher. The study has addressed the need to identify high-risk women for gestational diabetes mellitus early in pregnancy so that timely interventions could be provided.
Researchers in the present study investigated the association of glycated haemoglobin (HbA1c) and homeostasis model assessment insulin resistance (HOMA-IR) with gestational diabetes mellitus (GDM) risk. They included pregnant women with HbA1c, fasting insulin, and fasting glucose (FG) measured at 15-20 weeks of gestation. These underwent oral glucose tolerance test (OGTT) at 24-28 weeks.
The study results explained as follows:
- Researchers identified 462 women, out of which 29.44 % of women developed GDM.
- Based on HbA1c and HOMA-IR, there were four groups in the study population, with the percentages of each group being 51.30%, 15.58%, 20.56%, and 12.55%, respectively.
- With the increase in HOMA-IR and HbA1c, GDM incidence increased with the increase of HOMA-IR and HbA1c, respectively.
- GDM risk increased when both HOMA-IR and HbA1c were elevated.
- In pregnant women < 35 years, there was no risk.
- Finally, we found significantly higher FG at 24-28 weeks in the high HOMA-IR and HbA1c group among GDM-positive pregnant women.
The study has highlighted that GDM incidence increases with increasing HOMA-IR and HbA1c, respectively carrying the highest risk when maternal HOMA- IR and HbA1c are elevated in pregnant women aged ≥ 35 years.
They said, based on the results of our study, we found that among pregnant women with GDM, fasting glucose is higher at 24-28 weeks in those with elevated IR and HbA1c, independent of age.
Further reading:
Combining HbA1c and insulin resistance to assess the risk of gestational diabetes mellitus: a prospective cohort study. https://doi.org/10.1016/j.diabres.2023.110673
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751